Revelation Biosciences Stock Quote REVB - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

1.52

Bid

1.51

Ask

1.60

Volume

38,231

1.51 Day's Range 1.64

1.51 52 Week Range 28.20

Market Cap

2.482M

Previous Close

1.59

Open

1.64

Last Trade

1.53

Last Trade Time

16:00:00

Financial Volume

$ 59,062

VWAP

1.5449

Average Volume (3m)

711,945

Shares Outstanding

1,632,935

Dividend Yield

PE Ratio

-0.14

Earnings Per Share (EPS)

-0.07

Revenue

Net Profit

-120k

Revelation Biosciences Inc is a clinical-stage life sciences company focused on the development of immunologic-based therapies for the prevention and treatment of disease. It has several product candidates in development. REVTx-99, the lead therapeutic candidate, is an intranasal immunomodulator to ... Revelation Biosciences Inc is a clinical-stage life sciences company focused on the development of immunologic-based therapies for the prevention and treatment of disease. It has several product candidates in development. REVTx-99, the lead therapeutic candidate, is an intranasal immunomodulator to prevent or treat infections caused by various respiratory viruses such as SARS-CoV-2, including its variants, influenza A and B, parainfluenza, rhinovirus, and RSV. REVTx-99 is also being developed for other indications such as: allergic rhinitis and chronic nasal congestion. REVTx-200 is an intranasal immunomodulator adjunct to be used in combination with an intramuscular vaccination for more complete immunity. REVTx-200 is based on the same technology used in REVTx-99. Show more

Sector

Pharmaceutical Preparations

Industry

Blank Checks

Headquarters

Lewes, Delaware, USA

Founded

2022

Revelation Biosciences Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker REVB. The last closing price for Revelation Biosciences was $1.59. Over the last year, Revelation Biosciences shares have traded in a share price range of $ 1.51 to $ 28.20.

Revelation Biosciences currently has 1,632,935 shares outstanding. The market capitalization of Revelation Biosciences is $2.60 million. Revelation Biosciences has a price to earnings ratio (PE ratio) of -0.14.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.12	-7.31707317073	1.64	1.74	1.51	43139	1.62145332	CS
4	-0.36	-19.1489361702	1.88	2.14	1.51	120207	1.78414339	CS
12	-0.83	-35.3191489362	2.35	3.8	1.51	711945	2.34540397	CS
26	-16.1	-91.3734392736	17.62	25.26	1.51	521214	3.64858391	CS
52	-23.08	-93.8211382114	24.6	28.2	1.51	313967	5.77081566	CS
156	-8797.48	-99.9827253097	8799	10237.5	1.51	1216024	931.51184355	CS
260	-8797.48	-99.9827253097	8799	10237.5	1.51	1216024	931.51184355	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
JTAIJet AI Inc	$ 0.5372 (79.73%)	5.57M
IMNNImunon Inc	$ 1.69 (42.02%)	1.54M
SPCBSuperCom Ltd	$ 0.2195 (15.53%)	2.68M
FFIVF5 Inc	$ 203.75 (14.73%)	230.76k
AISPAirship AI Holdings Inc	$ 4.09 (14.57%)	314.23k
SYMSymbotic Inc	$ 29.44 (-17.37%)	589.04k
EKSOEkso Bionics Holdings Inc	$ 1.30 (-12.46%)	89.06k
VSEEVSee Health Inc	$ 3.28 (-11.11%)	14.16k
LSCCLattice Semiconductor Corp	$ 49.00 (-10.84%)	291.83k
ONMDOneMedNet Corporation	$ 1.04 (-9.57%)	17.74k
OXLCOxford Lane Capital Corporation	$ 5.58 (0.36%)	7.49M
JTAIJet AI Inc	$ 0.5372 (79.73%)	5.57M
TLRYTilray Brands Inc	$ 2.03 (11.23%)	5.49M
NVDANVIDIA Corporation	$ 111.58 (-0.01%)	5.43M
BKRBaker Hughes Company	$ 38.47 (0.00%)	3.84M